A patient develops more than a 50% drop in platelets within a week of starting heparin. What is the most likely diagnosis?

A patient develops more than a 50% drop in platelets within a week of starting heparin. What is the most likely diagnosis?

• A. Heparin-Induced Thrombocytopenia
• B. Immune thrombocytopenia
• C. DIC
• D. TTP

Answer: (A)

Thrombocytopenia after starting heparin points to heparin-induced thrombocytopenia, an immune-mediated reaction where antibodies form against the heparin–platelet factor 4 complex. These antibodies activate platelets, leading to their consumption and a drop in platelet count, while also increasing the risk of clotting. The typical pattern is a substantial platelet drop (often more than 50%) that occurs about 5–10 days after heparin exposure, though it can be sooner if there was prior heparin exposure. This timing and strong association with heparin exposure make HIT the most likely diagnosis in this scenario. Other causes don’t fit as well: immune thrombocytopenia is an isolated autoimmune platelet destruction not tied to heparin use; DIC involves widespread coagulopathy with abnormal coagulation tests and consumption of clotting factors; TTP presents with microangiopathic hemolytic anemia and neurologic/renal symptoms in addition to thrombocytopenia.

Thrombocytopenia after starting heparin points to heparin-induced thrombocytopenia, an immune-mediated reaction where antibodies form against the heparin–platelet factor 4 complex. These antibodies activate platelets, leading to their consumption and a drop in platelet count, while also increasing the risk of clotting.

The typical pattern is a substantial platelet drop (often more than 50%) that occurs about 5–10 days after heparin exposure, though it can be sooner if there was prior heparin exposure. This timing and strong association with heparin exposure make HIT the most likely diagnosis in this scenario.

Other causes don’t fit as well: immune thrombocytopenia is an isolated autoimmune platelet destruction not tied to heparin use; DIC involves widespread coagulopathy with abnormal coagulation tests and consumption of clotting factors; TTP presents with microangiopathic hemolytic anemia and neurologic/renal symptoms in addition to thrombocytopenia.